ArticleOncology letters2021

Ginsenoside Rg5 inhibits cancer cell migration by inhibiting the nuclear factor-κB and erythropoietin-producing hepatocellular receptor A2 signaling pathways.

Leixin Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.